Works matching DE "GAUCHER'S disease treatment"
Results: 115
Goal-oriented therapy with miglustat in Gaucher disease.
- Published in:
- Current Medical Research & Opinion, 2009, v. 25, n. 1, p. 23, doi. 10.1185/03007990802576518
- By:
- Publication type:
- Article
Treatment of severe pulmonary hypertension with inhaled iloprost.
- Published in:
- 2003
- By:
- Publication type:
- Case Study
Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher..
- Published in:
- Annals of Internal Medicine, 1996, v. 125, n. 11, p. 901, doi. 10.7326/0003-4819-125-11-199612010-00005
- By:
- Publication type:
- Article
Enzyme therapy in type 1 Gaucher disease: Comparative efficacy of mannose-terminated...
- Published in:
- Annals of Internal Medicine, 1995, v. 122, n. 1, p. 33, doi. 10.7326/0003-4819-122-1-199501010-00005
- By:
- Publication type:
- Article
Pharmacological treatment of pediatric Gaucher disease.
- Published in:
- Expert Review of Clinical Pharmacology, 2018, v. 11, n. 12, p. 1183, doi. 10.1080/17512433.2018.1549486
- By:
- Publication type:
- Article
Drug to treat form of Gaucher's disease gains US FDA approval.
- Published in:
- Expert Review of Clinical Pharmacology, 2012, v. 5, n. 4, p. 357
- By:
- Publication type:
- Article
Cytokines in Gaucher disease: Role in the pathogenesis of bone and pulmonary disease.
- Published in:
- Egyptian Journal of Medical Human Genetics, 2015, v. 16, n. 3, p. 207, doi. 10.1016/j.ejmhg.2015.02.001
- By:
- Publication type:
- Article
Histologic Findings of Femoral Heads From Patients With Gaucher Disease Treated With Enzyme Replacement.
- Published in:
- American Journal of Clinical Pathology, 2013, v. 140, n. 1, p. 91, doi. 10.1309/AJCPFVSAEGO67NGT
- By:
- Publication type:
- Article
Velaglucerase alfa as a therapeutic option for Gaucher disease.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2011, v. 6, n. 1, p. 13, doi. 10.1586/EEM.10.74
- By:
- Publication type:
- Article
Shire submits European marketing authorization application for velaglucerase a for the treatment of type 1 Gaucher's Disease.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2010, v. 5, n. 1, p. 4
- Publication type:
- Article
Velaglucerase alfa.
- Published in:
- Australian Prescriber, 2012, v. 35, n. 6, p. 210
- Publication type:
- Article
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study.
- Published in:
- Annals of Clinical & Translational Neurology, 2016, v. 3, n. 3, p. 200, doi. 10.1002/acn3.292
- By:
- Publication type:
- Article
Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: two case reports.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease.
- Published in:
- Orphanet Journal of Rare Diseases, 2014, v. 9, n. 1, p. 2, doi. 10.1186/1750-1172-9-51
- By:
- Publication type:
- Article
Reducing selection bias in case-control studies from rare disease registries.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Echocardiographic assessment in children with Gaucher disease receiving enzyme replacement therapy.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Quality of life assessment in adults with type 1 Gaucher disease.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Glucocerebrosidase level in the cerebrospinal fluid during enzyme replacement therapy – unsuccessful treatment of the neurological abnormality in type 2 Gaucher disease.
- Published in:
- European Journal of Pediatrics, 2003, v. 162, n. 7/8, p. 524, doi. 10.1007/s00431-001-0859-7
- By:
- Publication type:
- Article
Improvement of neurological symptoms by enzyme replacement therapy for Gaucher disease type IIIb.
- Published in:
- 2001
- By:
- Publication type:
- Case Study
α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
- Published in:
- Molecular Neurodegeneration, 2018, v. 12, p. 1, doi. 10.1186/s13024-017-0233-5
- By:
- Publication type:
- Article
Gaucher Disease for Hematologists.
- Published in:
- Turkish Journal of Hematology, 2022, v. 39, n. 2, p. 136, doi. 10.4274/tjh.galenos.2022.2021.0683
- By:
- Publication type:
- Article
β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01143
- By:
- Publication type:
- Article
Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes.
- Published in:
- PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0170268
- By:
- Publication type:
- Article
Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0168135
- By:
- Publication type:
- Article
Glycosylation and functionality of recombinant ß-glucocerebrosidase from various production systems.
- Published in:
- Bioscience Reports, 2013, v. 33, n. 5, p. 771, doi. 10.1042/BSR20130081
- By:
- Publication type:
- Article
TYPE 2 GAUCHER DISEASE: ONSET AND EVOLUTION - CASE REPORT.
- Published in:
- Romanian Journal of Pediatrics / Revista Romana de Pediatrie, 2015, v. 64, n. 3, p. 293, doi. 10.37897/rjp.2015.3.12
- By:
- Publication type:
- Article
RIPK3 as a potential therapeutic target for Gaucher's disease.
- Published in:
- Nature Medicine, 2014, v. 20, n. 2, p. 204, doi. 10.1038/nm.3449
- By:
- Publication type:
- Article
How we manage Gaucher Disease in the era of choices.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 4, p. 467, doi. 10.1111/bjh.15402
- By:
- Publication type:
- Article
2012 The year in review.
- Published in:
- Chemistry & Industry, 2012, v. 76, n. 11, p. 32
- By:
- Publication type:
- Article
Terapia de reemplazo enzimático en una paciente con enfermedad de Gaucher tipo III.
- Published in:
- Acta Pediatrica de Mexico, 2012, v. 33, n. 1, p. 9
- By:
- Publication type:
- Article
A branch retinal artery occlusion in a patient with Gaucher disease.
- Published in:
- 2012
- By:
- Publication type:
- Report
The Spectrum of Neurological Manifestations Associated with Gaucher Disease.
- Published in:
- Diseases, 2017, v. 5, n. 1, p. 10, doi. 10.3390/diseases5010010
- By:
- Publication type:
- Article
Critical appraisal of observational studies on enzyme replacement therapy for Gaucher's Disease.
- Published in:
- JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde, 2015, v. 7, n. 3, p. 148
- By:
- Publication type:
- Article
Recombinant Glucocerebrosidase (Imiglucerase) as a Therapy for Gaucher Disease.
- Published in:
- BioDrugs, 2010, v. 24, n. 1, p. 41, doi. 10.2165/11318540-000000000-00000
- By:
- Publication type:
- Article
Alglucerase: Practical Guidance on Appropriate Dosage and Administration in Patients with Gaucher Disease.
- Published in:
- BioDrugs, 1998, v. 9, n. 1, p. 11
- By:
- Publication type:
- Article
FROM SYMPTOMS AND SIGNS TO DIAGNOSIS IN A RARE DISEASE, TYPE I GAUCHER DISEASE.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Evaluation of the Nutritional Status of Gaucher Disease Type I Patients under Enzyme Replacement Treatment.
- Published in:
- Nutrients, 2022, v. 14, n. 15, p. 3180, doi. 10.3390/nu14153180
- By:
- Publication type:
- Article
Low-dose high-frequency enzyme replacement therapy for very young children with severe Gaucher...
- Published in:
- 1994
- By:
- Publication type:
- Abstract
Achievement of Therapeutic Goals with Low-Dose Imiglucerase in Gaucher Disease: A Single-Center Experience.
- Published in:
- Advances in Hematology, 2013, p. 1, doi. 10.1155/2013/151506
- By:
- Publication type:
- Article
Enfermedad neuropática de Gaucher tratada con terapia de reemplazo a largo plazo.
- Published in:
- Revista Medica del IMSS, 2013, v. 51, n. 3, p. 340
- By:
- Publication type:
- Article
Immunogenicity of glycans on biotherapeutic drugs produced in plant expression systems—The taliglucerase alfa story.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0186211
- By:
- Publication type:
- Article
Miglustat: withdrawal by manufacturer.
- Published in:
- WHO Drug Information, 2008, v. 22, n. 1, p. 21
- Publication type:
- Article
Reply to vom dahl et al.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 4, p. 1086, doi. 10.1046/j.1365-2141.2001.02821-10.x
- By:
- Publication type:
- Article
Interruption in enzyme replacement therapy for gaucher disease.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 4, p. 1087, doi. 10.1046/j.1365-2141.2001.02821-11.x
- By:
- Publication type:
- Article
Withdrawal of enzyme replacement therapy in Gaucher's disease.
- Published in:
- British Journal of Haematology, 2000, v. 110, n. 2, p. 488, doi. 10.1046/j.1365-2141.2000.02177.x
- By:
- Publication type:
- Article
Overall assessment of patients with type 1 Gaucher disease: a single-centre's experience.
- Published in:
- Journal of Rare Diseases, 2023, v. 2, n. 1, p. 1, doi. 10.1007/s44162-023-00019-6
- By:
- Publication type:
- Article
Target identification: Targeting neuronal loss in Gaucher's disease.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 178, doi. 10.1038/nrd4270
- By:
- Publication type:
- Article
Velaglucerase alfa.
- Published in:
- 2010
- By:
- Publication type:
- journal article